Phase 3 Colorectal Cancer Metastatic Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
Shanghai Kechow Pharma, Inc.165 enrolled1 locationNCT06008119
Recruiting
Phase 3
Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer
Colorectal Cancer MetastaticColorectal Cancer Recurrent
Second Affiliated Hospital, School of Medicine, Zhejiang University302 enrolled1 locationNCT06992648
Recruiting
Phase 3
DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases
Colorectal Cancer MetastaticLiver Neoplasm
Tehran University of Medical Sciences116 enrolled1 locationNCT06555003